Indaptus Therapeutics (INDP) Cash & Equivalents (2020 - 2026)
Indaptus Therapeutics (INDP) recorded Cash & Equivalents of $7.55 million in Q2 2026, up 22.7% from $6.16 million a year earlier and up 404.4% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Indaptus Therapeutics reported Cash & Equivalents of $8.51 million, up 47.0% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 39.0% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $5.79 million in FY2024 (-56.7%), $13.36 million in FY2023 (+38.8%), $9.63 million in FY2022 (-75.4%) and $39.13 million in FY2021.
- Quarterly Cash & Equivalents has ranged from $1.5 million in Q1 2026 to $41.86 million in Q3 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in two of the last eight quarters, with an average decline of 24.9%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 227.7% in Q1 2022, against a decline of 83.9% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.5 million (Q1 2026), $8.51 million (Q4 2025) and $5.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Indaptus Therapeutics | 135.92 Mn | 108.53 Mn | - | 7.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.55 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 8.51 Mn |
| Sep 30, 2025 | 5.83 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Dec 31, 2024 | 5.79 Mn |
| Sep 30, 2024 | 7.38 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 9.74 Mn |
| Dec 31, 2023 | 13.36 Mn |
| Sep 30, 2023 | 15.96 Mn |
| Jun 30, 2023 | 12.70 Mn |
| Mar 31, 2023 | 6.81 Mn |
| Dec 31, 2022 | 9.63 Mn |
| Sep 30, 2022 | 6.72 Mn |
| Jun 30, 2022 | 14.26 Mn |
| Mar 31, 2022 | 33.22 Mn |
| Dec 31, 2021 | 39.13 Mn |
| Sep 30, 2021 | 41.86 Mn |
API Access
Indaptus Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();